VivoSeq
Other

MCI

0

Pipeline Programs↗

4

Active Trials↗

2

Companies Involved↗

MCI is an early-stage landscape with 0 programs across 2 companies. The most active players are Tanabe Pharma Corporation, Acumen Pharmaceuticals.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

81/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Tanabe Pharma Corporation logo

Tanabe Pharma Corporation

0 programs

PreclinicalA

Acumen Pharmaceuticals

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

22

clinical trials

Completed13 · 59%
Terminated3 · 14%
Not yet recruiting2 · 9%
Unknown status2 · 9%
Active, not recruiting1 · 5%
Recruiting1 · 5%

Clinical Trials

Trial Activity

22 trials

EGb 761 in the Syndrome of MCI With Concomitant CVD
Recruiting·NNational Neuroscience Institute·Phase 2·NCT04525144·134 enrolled
Evaluation of Trazodone in OSA-MCI
Active, not recruiting·—·Phase 4·NCT05209035·134 enrolled
Development of a Novel Multidimensional Therapeutic Intervention Protocol for MCI
Not yet recruiting·—·N/A·NCT07196592·300 enrolled
The Effect of Lavender Aromatherapy on Cognitive Function in Older Adults With Mild Cognitive Impairment
Not yet recruiting·CChina Medical University, China·Preclinical·NCT07688382·70 enrolled
Triamcinolone Levels in Cochlear Perilymph
Completed·—·Phase 1·NCT03248856·40 enrolled
Subcutaneous Sodium Deoxycholate Injections With or Without Triamcinolone for Reduction of Submental Fat
Completed·GGoldman, Butterwick, Fitzpatrick and Groff·Phase 4·NCT03241563·20 enrolled
Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders
Completed·National Eye Institute (NEI)·Phase 1·NCT00071227·16 enrolled
Bioequivalency Study of Famciclovir 500 mg Tablets Under Fed Conditions
Completed·RRoxane Laboratories·N/A·NCT01321502·31 enrolled
A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD
Completed·AAcumen Pharmaceuticals·Phase 1·NCT04931459·65 enrolled
Simplifying the Shang Ring Technique for Circumcision of Men and Boys
Completed·EEngenderHealth·N/A·NCT02390310·574 enrolled
A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects
Completed·Tanabe Pharma Corporation logoTanabe Pharma Corporation·Phase 1·NCT04029090·27 enrolled
Bioequivalency Study of Famciclovir 500 mg Tablets Under Fasted Conditions
Completed·RRoxane Laboratories·N/A·NCT01321515·36 enrolled
Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser
Completed·HHospital de Clinicas de Porto Alegre·N/A·NCT00668239·14 enrolled
Kybella With Triamcinolone
Completed·GGoldman, Butterwick, Fitzpatrick and Groff·Phase 4·NCT03361176·30 enrolled
Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF
Completed·MMedical University of Vienna·Phase 1·NCT04658836·21 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)